Cargando…

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?

Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also the use of clopidogrel is not without side ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montalto, Massimo, Porto, Italo, Gallo, Antonella, Camaioni, Claudia, Della Bona, Roberta, Grieco, Antonio, Crea, Filippo, Landolfi, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155782/ https://www.ncbi.nlm.nih.gov/pubmed/21860799 http://dx.doi.org/10.1155/2011/867964

Ejemplares similares

Treatment of In-Stent Stenosis Following Flow Diversion of Intracranial Aneurysms with Cilostazol and Clopidogrel
por: Dowlati, Ehsan, et al.
Publicado: (2021)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports
por: Yuan, Huai-Wu, et al.
Publicado: (2020)

Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
por: Sheu, Jiunn-Jye, et al.
Publicado: (2012)

Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation
por: Liu, Hui, et al.
Publicado: (2023)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Detection of Clopidogrel Hyporesponsiveness Using a Point-of-Care Assay and the Impact of Additional Cilostazol Administration after Coronary Stent Implantation in Diabetic Patients
por: Yang, Tae-Hyun, et al.
Publicado: (2011)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy
por: Tajima, Hayato, et al.
Publicado: (2018)

Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
por: Lee, Tsong-Hai, et al.
Publicado: (2020)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019)

Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology
por: Merlo, Andrea Carlo, et al.
Publicado: (2022)

Clopidogrel-induced neutropenia in a 84-year-old patient: A case report
por: Pinto, Fernando M.C., et al.
Publicado: (2022)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011)

Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
por: Kalantzi, Kallirroi, et al.
Publicado: (2020)

Peripheral levels of circulating progenitor cells correlate with area at risk and microvascular obstruction at cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction
por: Porto, Italo, et al.
Publicado: (2011)

Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018)

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial
por: Burzotta, Francesco, et al.
Publicado: (2012)

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
por: Miura, Takashi, et al.
Publicado: (2022)

Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders
por: Lee, Seung-Hyun, et al.
Publicado: (2013)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Strategy for the Treatment of Clopidogrel Low Responsiveness in Diabetes Mellitus and Stent Implantation
por: Kim, Jang-Young
Publicado: (2009)

Acute Multiple In-Stent Thromboses in a Patient With Clopidogrel-Fluconazole Interaction
por: El Khoury, Antoine, et al.
Publicado: (2022)

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
por: Noh, Yoojin, et al.
Publicado: (2016)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Quantitative blush evaluator (QuBE) accurately quantifies microvascular dysfunction in patients with ST-Elevation Myocardial Infarction; comparison with Cardiovascular Magnetic Resonance
por: Hamilton-Craig, Christian, et al.
Publicado: (2011)

Revascularization of acute stent thrombosis caused by diarrhea after carotid artery stenting in an intermediate clopidogrel metabolizer
por: Wang, Huaishun, et al.
Publicado: (2023)

Recurrent neutropenia and chronic diarrhea following thymectomy: the good, the bad, and the ugly
por: Oyenuga, Mosunmoluwa, et al.
Publicado: (2021)

Intralobar Pulmonary Sequestration and Increased Serum CA 19-9
por: Montalto, Massimo, et al.
Publicado: (2017)

Recurrent chest pain: ‘what is essential is invisible to the eye?’
por: D’Amario, Domenico, et al.
Publicado: (2019)

A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation
por: Park, Yae Min, et al.
Publicado: (2012)

Clopidogrel resistance "Live" – the risk of stent thrombosis should be evaluated before procedures
por: Motovska, Zuzana, et al.
Publicado: (2009)

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers
por: Decker, Carole, et al.
Publicado: (2008)

Long-term complications after stent assist coiling dependent on clopidogrel response
por: Shoda, Kenji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svd005412oefgsh599tmdkb4mr